Peptide Profile

HGH

Human Growth Hormone (Somatropin)

Fda Approved10 sourcesShop HGH

Overview

Composition

Naturally occurring peptide hormone secreted by the anterior pituitary gland, consisting of 191 amino acids

Mechanism of Action

Stimulates growth, cell reproduction, regeneration, and metabolism throughout life; promotes linear growth in children, maintains lean body mass, supports bone density, enhances lipolysis (fat breakdown), and regulates carbohydrate and protein metabolism

Primary Effects

Recombinant somatropin is a synthetic version identical to endogenous HGH, used for approved replacement indications; body-composition and recovery claims outside labeled use require separate evidence review

Discovery & Background

First identified in the 1920s through early pituitary research, with growth-promoting effects confirmed in animal experiments

In the 1950s, extracted cadaveric human growth hormone became available for clinical use to treat severe growth deficiencies in children; this pituitary-derived form was used until the early 1980s when concerns arose over Creutzfeldt-Jakob disease transmission; recombinant DNA technology then enabled biosynthetic somatropin production

FDA-approved for specific deficiencies (pediatric GHD, Turner syndrome, Prader-Willi syndrome, idiopathic short stature, adult GHD) but not for performance enhancement or routine aging

Research Overview

Research spans decades, with substantial data from animal models and human studies including randomized controlled trials and long-term registries

01
Confirmed benefits in growth hormone deficiency (GHD): improved height in children, increased lean mass, reduced fat mass, better bone density, enhanced quality of life in adults
02
Approved indications include pediatric GHD, Turner syndrome, Prader-Willi syndrome, idiopathic short stature, and adult GHD
03
Off-label exploration for aging or athletic-performance claims shows mixed results, with limited evidence for broad benefit
04
No approval for performance enhancement or routine aging
05
Safety depends on indication, patient factors, and monitoring; risks include metabolic changes and unresolved long-term concerns

FDA-approved for specific deficiencies but not for performance enhancement or routine aging

Safety Considerations

Monitoring

IGF-1 levels
Glucose and HbA1c
Thyroid function
Weight and body composition
Overall health checks

Side Effects

Common

Water retention
Joint pain
Carpal tunnel syndrome
Insulin resistance
Headaches
Edema and musculoskeletal discomfort are recognized labeled concerns

Local

Local irritation can occur with approved somatropin products
Product-specific reactions should be interpreted against official labeling

Contraindications

Active malignancy
Uncontrolled diabetes
Severe illness
Not approved for routine aging or performance enhancement

Educational Notice

HGH/somatropin has clear evidence for approved deficiency states, but non-medical use for aging, body composition, recovery, or performance carries risk and lacks regulatory approval.

References